Menlo Ventures Company Profile

13:14 EDT 22nd September 2018 | BioPortfolio

Menlo Ventures has invested in more than 300 companies in a wide range of industries since its inception in 1976. To view our current portfolio or a list of select prior investments, please choose from the following industry categories.


3000 Sand Hill Road Building 4, Suite 100
Menlo Park
United States of America


Phone: (650) 854-8540
Fax: (650) 854-7059

News Articles [405 Associated News Articles listed on BioPortfolio]

Menlo puts brave face on serlopitant setback

Californian biotech Menlo Therapeutics is solely focused on the development of serlopitant, so it was…

Press release story title: Cofactor Genomics announces $18M funding in an oversubscribed Series-A round to bring RNA to Precision Medicine

San Francisco, California, 19th September 2017 / Sciad Newswire / Cofactor Genomics, developer of a leading platform for RNA sequencing and expression analysis, today announced $18M in financing led...

Menlo reports negative top-line results in ATOMIK trial

Menlo Therapeutics has reported negative top-line results from the ATOMIK study, a Phase II clinical trial analysing the efficacy, safety...Read More... The post Menlo reports negative top-line result...

Menlo Therapeutics Moves Paul Kwon to Chief Scientific Officer

Paul Kwon, the chief medical officer of Menlo Therapeutics (NASDAQ: MNLO) for the past two years, will now become the Redwood City, CA, company’s chief scientific officer. In a related move, Mary Sp...

Menlo Therapeutics starts enrolment in Phase lll trial of serlopitant

Menlo Therapeutics has begun patient enrolment in the second of two Phase lll trials of serlopitant for the treatment of...Read More... The post Menlo Therapeutics starts enrolment in Phase lll trial ...

League raises fresh capital to grow employee health benefits platform

The Canadian startup secured C$62 million (or about $47.5 million) in a round led by TELUS Ventures. Wittington Ventures, OMERS, RBC Ventures, Real Ventures, Infinite Potential Group and BDC IT Ventu...

RubiconMD wraps up $13.8M Series B to connect PCPs and specialists

The round, which was led by HLM Ventures and Optum Ventures, included participation from Centene Corporation, Alma Mundi Ventures and others.

Failed Clinical Trial: Menlo's Stock Tanks

Menlo Therapeutics' stock dropped 55 percent in premarket trading after announcing its serlopitant failed to meet primary and secondary endpoints in a Phase II clinical trial.

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Avant ex [B4 Ventures LLC]

B4 Brands: Avant EX Instant Hand Sanitizer

Avant foaming hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Foaming Hand Sanitizer - Fragrance Free

Avant original instant hand sanitizer [B4 Ventures LLC]

B4 Brands: Avant Original Instant Hand Sanitizer

Aterra antibacterial hand wash [B4 Ventures LLC]

B4 Brands: Aterra Antibacterial Hand Soap

Avant original - fragrance free [B4 Ventures LLC]

B4 Brands: Avant Original - Fragrance Free Instant Hand Sanitizer

PubMed Articles [7 Associated PubMed Articles listed on BioPortfolio]

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

American hospitals are increasingly turning to service outsourcing to reduce costs, including laboratory services. Studies of this practice have largely focused on nonacademic medical centers. In cont...

Estimating and valuing the carbon release in scenarios of land-use and climate changes in a Brazilian coastal area.

Deforestation is a significant source of man-made carbon in the atmosphere, contributing to the greenhouse gas (GHG) effect. Although carbon releases are associated to the ecosystem functions of clima...

6-Minute walk test predicts prolonged hospitalization in patients undergoing transcatheter mitral valve repair by MitraClip.

The 6-minute walk test (6MWT) is a simple functional test that can predict exercise capacity and is widely employed to assess treatment outcomes. Although mortality with transcatheter mitral valve rep...

"Yes, we know!" (Over)confidence in general knowledge among Austrian entrepreneurs.

Overconfidence has been reported to be a common bias among entrepreneurs and might be one cause of the high failure rates observed for new ventures. In this study, we investigate the overconfidence bi...

Percutaneous Edge-to-Edge Transcatheter Mitral Valve Repair: Current Indications and Future Perspectives.

Mitral regurgitation (MR) is the most prevalent valvular heart disease (VHD) and represents an important cause of heart failure. Medical therapy has a limited role in improving symptoms and does not h...

Clinical Trials [2 Associated Clinical Trials listed on BioPortfolio]

Evaluation of a Digital Microscope for Malaria

Light microscopy, which is based on century-old technology, remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalaria...

Field Evaluation of a Device for Automated Malaria Microscopy (Autoscope Version 2)

Microscopy remains a key indicator in drug efficacy testing performed in the context of clinical trials for monitoring existing antimalarials or in the context of regulatory clinical trial...

Companies [600 Associated Companies listed on BioPortfolio]

Menlo Ventures

Menlo Ventures has invested in more than 300 companies in a wide range of industries since its inception in 1976. To view our current portfolio or a list of select prior investments, please choose fro...

GE Ventures

GE Ventures is committed to identifying, scaling and accelerating ideas that will make the world work better. Focused on the areas of software, advanced manufacturing, energy and ...

Menlo Microsystems

Headquartered in Irvine, California, Menlo Micro is reimagining one of the most fundamental building blocks of electronic systems – the electronic switch. The company’s ...

Khosla Ventures

Khosla Ventures offers venture assistance, strategic advice and capital to entrepreneurs. The firm helps entrepreneurs extend the potential of their ideas in breakthrough technolo...

Ardian Inc.

Privately held Ardian Inc., based in Mountain View, Calif., develops catheter-based therapies to treat hypertension and related conditions. Ardian is the eighth company created by...

More Information about "Menlo Ventures" on BioPortfolio

We have published hundreds of Menlo Ventures news stories on BioPortfolio along with dozens of Menlo Ventures Clinical Trials and PubMed Articles about Menlo Ventures for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Menlo Ventures Companies in our database. You can also find out about relevant Menlo Ventures Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record